WilliamThomasJohnsonDO

PubMed

• Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in T- and/or NK-cell lymphoma patients.
  Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, Maria E Arcila, Andriy Derkach, Ying Liu, William T Johnson, Santosha A Vardhana, Steven M Horwitz, A...> ;Blood Advances. 2024 Apr 9
• 3 citations
  TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.
  William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver, Catherine R Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan...> ;Blood Advances. 2023 Sep 12
• 1 citations
  Retrospective characterization of nodal marginal zone lymphoma.
  Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Ahmet Dogan, Zachary D Epstein-Peterson, Lorenzo Falchi, Paul A Hamlin,...> ;Blood Advances. 2023 Sep 12
• 31 citations
  Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
  Ombrello, A. K., Ombrello, A. K., Melissa R Hines, Tristan E Knight, Kevin O McNerney, Mark B Leick, Tania Jain, Sairah Ahmed, Matthew J Frigault, Joshua A Hill, Micha...> ;Transplantation and Cellular Therapy. 2023 Jul 1
• Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms.
  Colleen Isabelle, William T Johnson, Kathleen McConnell, Ashley Vogel, Jonathan E Brammer, Amy Boles, Robyn Keller, Paola Sindaco, Liam Nisenfeld, Guldeep Uppal, Neda ...> ;Blood Advances. 2023 Jul 25
• 3 citations
  Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant L...
  Jennifer Hong, William T Johnson, Saritha Kartan, Anitha S Gonsalves, Jonathan M Fenkel, Jerald Z Gong, Pierluigi Porcu> ;Current Oncology. 2021 Dec 2
• 69 citations
  Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
  Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Samia Sohail, Alayna Santa...> ;Journal of Clinical Oncology. 2021 Jun 25
• 9 citations
  Clinical characteristics and outcomes of black patients with mycosis fungoides and Sézary syndrome: a subgroup analysis of the phase III MAVORIC trial
  William T. Johnson, Saritha Kartan, Kelsey Sokol, Neda Nikbakht, Pierluigi Porcu> ;Leukemia & Lymphoma. 2021 Feb 22
• 1 citations
  The EZ-riding NK/T-cell lymphoma
  William T. Johnson, Anjali Mishra> ;Blood. 2019 Dec 5
• 9 citations
  Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL).
  Kelsey Sokol, Saritha Kartan, William T. Johnson, Onder Alpdogan, Neda Nikbakht, Bradley M. Haverkos, Jerald Z. Gong, Pierluigi Porcu> ;Frontiers in Oncology. 2019 Jun 13
• 2 citations
  Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?
  William T. Johnson, Anjali Mishra, Adam F. Binder, Alejandro A. Gru, Pierluigi Porcu> ;Haematologica. 2019 May 1
• 32 citations
  Systemic therapy of cutaneous T-cell lymphoma (CTCL)
  Onder Alpdogan, Saritha Kartan, William T. Johnson, Kelsey Sokol, Pierluigi Porcu> ;Chinese Clinical Oncology. 2019 Feb 1
• 10 citations
  The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
  Saritha Kartan, William T. Johnson, Kelsey Sokol, Onder Alpdogan, Alejandro A. Gru, Neda Nikbakht, Pierluigi Porcu> ;Chinese Clinical Oncology. 2019 Jan 9
• 16 citations
  Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
  Adetokunbo Folashade Oluwasanjo, Saritha Kartan, William T. Johnson, Onder Alpdogan, Alejandro A. Gru, Anjali Mishra, Bradley M. Haverkos, Jerald Z. Gong, Pierluigi Porcu> ;Cancer Treatment and Research. 2019 Jan 1
• 14 citations
  Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: a concise review.
  William T. Johnson, Reetu Mukherji, Saritha Kartan, Neda Nikbakht, Pierluigi Porcu, Onder Alpdogan> ;Chinese Clinical Oncology. 2019 Feb 1
• Three Thrombi at Onset: Behçet's Disease.
  William T. Johnson, Sharif Ahmed, Gary V. Gordon, David A. Cohen> ;The American Journal of Medicine. 2017 Dec 1
• 4 citations
  Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment.
  William T. Johnson, Rebecca J. Leeman-Neill, Parth Patel, Jonhan Ho, Lisa M. Grandinetti, Jaroslaw Jedrych, Fiona E. Craig> ;The American Journal of Dermatopathology. 2016 Nov 1
• 14 citations
  Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
  William T. Johnson, Parth Patel, Amanda Hernandez, Lisa M. Grandinetti, Arthur C. Huen, Stanley M. Marks, Jonhan Ho, Sara E. Monaco, Ronald Jaffe, Jennifer Picarsic> ;Journal of Cutaneous Pathology. 2016 Mar 1
• Join now to see all